Existing models, but not neutrophil-to-lymphocyte ratio, are prognostic in malignant mesothelioma
作者： T M Meniawy , J Creaney , R A Lake , A K Nowak
DOI: 10.1038/BJC.2013.504
关键词:
摘要: Existing models, but not neutrophil-to-lymphocyte ratio, are prognostic in malignant mesothelioma
nature.com
sci-hub.se 参考文章(22)
J.L. Schafer, Analysis of Incomplete Multivariate Data ,(1997)
Kei Suzuki, Kyuichi Kadota, Camelia S. Sima, Michel Sadelain, Valerie W. Rusch, William D. Travis, Prasad S. Adusumilli, Chronic inflammation in tumor stroma is an independent predictor of prolonged survival in epithelioid malignant pleural mesothelioma patients Cancer Immunology, Immunotherapy. ,vol. 60, pp. 1721- 1728 ,(2011) , 10.1007/S00262-011-1073-8
R. J. Francis, M. J. Byrne, A. A. van der Schaaf, J. A. Boucek, A. K. Nowak, M. Phillips, R. Price, A. P. Patrikeos, A. W. Musk, M. J. Millward, Early Prediction of Response to Chemotherapy and Survival in Malignant Pleural Mesothelioma Using a Novel Semiautomated 3-Dimensional Volume-Based Analysis of Serial 18F-FDG PET Scans The Journal of Nuclear Medicine. ,vol. 48, pp. 1449- 1458 ,(2007) , 10.2967/JNUMED.107.042333
David James Pinato, Francesco A. Mauri, Rathi Ramakrishnan, Lutful Wahab, Tyler Lloyd, Rohini Sharma, Inflammation-Based Prognostic Indices in Malignant Pleural Mesothelioma Journal of Thoracic Oncology. ,vol. 7, pp. 587- 594 ,(2012) , 10.1097/JTO.0B013E31823F45C1
Roderick J. Little, Ralph D'Agostino, Michael L. Cohen, Kay Dickersin, Scott S. Emerson, John T. Farrar, Constantine Frangakis, Joseph W. Hogan, Geert Molenberghs, Susan A. Murphy, James D. Neaton, Andrea Rotnitzky, Daniel Scharfstein, Weichung J. Shih, Jay P. Siegel, Hal Stern, The Prevention and Treatment of Missing Data in Clinical Trials The New England Journal of Medicine. ,vol. 367, pp. 1355- 1360 ,(2012) , 10.1056/NEJMSR1203730
S. Cedrés, M.A. Montero, P. Martinez, A. Martinez, V. Rodríguez-Freixinós, D. Torrejon, A. Gabaldon, M. Salcedo, S. Ramon y Cajal, E. Felip, Exploratory analysis of activation of PTEN–PI3K pathway and downstream proteins in malignant pleural mesothelioma (MPM) Lung Cancer. ,vol. 77, pp. 192- 198 ,(2012) , 10.1016/J.LUNGCAN.2012.02.022
A Burton, D G Altman, Missing covariate data within cancer prognostic studies: a review of current reporting and proposed guidelines British Journal of Cancer. ,vol. 91, pp. 4- 8 ,(2004) , 10.1038/SJ.BJC.6601907
Steven C. Kao, Janette Vardy, Mark Chatfield, Peter Corte, Nick Pavlakis, Christopher Clarke, Nico van Zandwijk, Stephen Clarke, Validation of prognostic factors in malignant pleural mesothelioma: a retrospective analysis of data from patients seeking compensation from the New South Wales Dust Diseases Board. Clinical Lung Cancer. ,vol. 14, pp. 70- 77 ,(2013) , 10.1016/J.CLLC.2012.03.011
James E. Herndon, Mark R. Green, A. Phillippe Chahinian, Joseph M. Corson, Yasunosuke Suzuki, Nicholas J. Vogelzang, Factors Predictive of Survival Among 337 Patients With Mesothelioma Treated Between 1984 and 1994 by the Cancer and Leukemia Group B Chest. ,vol. 113, pp. 723- 731 ,(1998) , 10.1378/CHEST.113.3.723
Steven Chuan-Hao Kao, Sonja Klebe, Douglas W. Henderson, Glen Reid, Mark Chatfield, Nicola J. Armstrong, Tristan D. Yan, Janette Vardy, Stephen Clarke, Nico van Zandwijk, Brian McCaughan, Low Calretinin Expression and High Neutrophil-To-Lymphocyte Ratio Are Poor Prognostic Factors in Patients with Malignant Mesothelioma Undergoing Extrapleural Pneumonectomy Journal of Thoracic Oncology. ,vol. 6, pp. 1923- 1929 ,(2011) , 10.1097/JTO.0B013E31822A3740